Search research articles
Contact Us
Filters
Showing results (491-500 of 565) with videos related to
Page
of 57
Sort By:
Radiation Oncology (London, England)
|
September 2, 2014
Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer
Gerald S M A Kerner, Leon F A van Dullemen, Erwin M Wiegman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 15, 2021
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2019
Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer
Menno Tamminga, Sanne de Wit, Caroline van de Wauwer, et al.
International Journal of Cancer
|
December 12, 2018
Single tube liquid biopsy for advanced non-small cell lung cancer
Sanne de Wit, Elisabetta Rossi, Sabrina Weber, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 10, 2020
Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes
Daan P Hurkmans, Menno Tamminga, Bram van Es, et al.
Targeted Oncology
|
February 19, 2021
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC
Jiacong Wei, Pei Meng, Miente Martijn Terpstra, et al.
Journal of Clinical Pathology
|
August 7, 2016
DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years
A Jasmijn Hubers, Daniëlle A M Heideman, Sylvia Duin, et al.
Cancers
|
July 27, 2024
Baseline Blood CD8<sup>+</sup> T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer
Hanneke Kievit, M Benthe Muntinghe-Wagenaar, Wayel H Abdulahad, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 29, 2015
Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis
Justine L Kuiper, Lizza E Hendriks, Anthonie J van der Wekken, et al.
Radiology
|
September 16, 2025
External Test of a Deep Learning Algorithm for Pulmonary Nodule Malignancy Risk Stratification Using European Screening Data
Noa Antonissen, Kiran Vaidhya Venkadesh, Renate Dinnessen, et al.
Page
of 57
Search research articles
Search
Showing results (491-500 of 565) with videos related to
Sort By:
Page
of 57
Radiation Oncology (London, England)
|
September 2, 2014
Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer
Gerald S M A Kerner, Leon F A van Dullemen, Erwin M Wiegman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 15, 2021
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2019
Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer
Menno Tamminga, Sanne de Wit, Caroline van de Wauwer, et al.
International Journal of Cancer
|
December 12, 2018
Single tube liquid biopsy for advanced non-small cell lung cancer
Sanne de Wit, Elisabetta Rossi, Sabrina Weber, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 10, 2020
Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes
Daan P Hurkmans, Menno Tamminga, Bram van Es, et al.
Targeted Oncology
|
February 19, 2021
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC
Jiacong Wei, Pei Meng, Miente Martijn Terpstra, et al.
Journal of Clinical Pathology
|
August 7, 2016
DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years
A Jasmijn Hubers, Daniëlle A M Heideman, Sylvia Duin, et al.
Cancers
|
July 27, 2024
Baseline Blood CD8<sup>+</sup> T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer
Hanneke Kievit, M Benthe Muntinghe-Wagenaar, Wayel H Abdulahad, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 29, 2015
Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis
Justine L Kuiper, Lizza E Hendriks, Anthonie J van der Wekken, et al.
Radiology
|
September 16, 2025
External Test of a Deep Learning Algorithm for Pulmonary Nodule Malignancy Risk Stratification Using European Screening Data
Noa Antonissen, Kiran Vaidhya Venkadesh, Renate Dinnessen, et al.
Page
of 57